The outcomes confirm conclusions drawn by Bagli et al. [1], who done a analyze that incorporated 10 patients diagnosed with CRAO who acquired HBOT. Besides acquiring twenty periods of HBOT, oral acetazolamide and topical beta-blockers have been administered to your patients on the earliest achievabl